Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
08/2000
08/24/2000WO2000049037A1 Growth hormone secretagogues
08/24/2000WO2000049026A1 Novel process for preparing alendronic acid
08/24/2000WO2000049018A1 2-amino-6-anilino-purines and their use as medicaments
08/24/2000WO2000049015A1 Pyridine compounds and their pharmaceutical use
08/24/2000WO2000049011A1 Prothease inhibitors
08/24/2000WO2000048996A2 β-ALANINE DERIVATIVES
08/24/2000WO2000048993A1 Arylaminoalkylamides
08/24/2000WO2000048992A1 Acylated aminoacetonitriles as cysteine protease inhibitors
08/24/2000WO2000048988A1 Phenylalaninol derivatives
08/24/2000WO2000048623A1 Novel amide derivatives as growth hormone secretagogues
08/24/2000WO2000048617A2 Connective tissue softening
08/24/2000WO2000048610A1 Chemical compounds
08/24/2000WO2000048609A1 Chemical compounds
08/24/2000WO2000048603A1 DIBENZO-AZEPINE DERIVATIVES AS αV INTEGRIN RECEPTOR ANTAGONISTS
08/24/2000WO2000048597A1 Systemic use of 5-ht3 receptor antagonists against rheumatic inflammatory processes
08/24/2000WO2000048591A1 Combinations for the treatment of diseases involving angiogenesis
08/24/2000WO2000048581A2 Use of 5-ht3 receptor antagonists for treating musculoeskeletal diseases
08/24/2000WO2000031051B1 Quinoline and quinoxaline compounds as pdgf-receptor and/or lck tyrosine kinase inhibitors
08/24/2000WO2000020434A9 Cadherin-like asymmetry protein-1, and methods for its use
08/24/2000WO2000015797A3 Compositions and methods for the treatment of immune related diseases
08/24/2000WO2000010536A9 Extended release buccal bioadhesive tablet
08/24/2000WO1999034763A3 Pharmaceutical compositions comprising thiram for inhibiting angiogenesis
08/24/2000DE4193302C2 Verwendung rekombinanter Antikörper spezifisch für TNF-alpha Using recombinant antibody specific for TNF-alpha
08/24/2000DE19859771C1 Wasserlösliche, stabile Brenztraubensäure(-salze)-enthaltende Formulierung Water-soluble, stable pyruvic acid (salts) -containing formulation
08/24/2000CA2371824A1 .beta.-alanine derivatives
08/24/2000CA2363670A1 Chemical compounds
08/24/2000CA2362943A1 Pyk2 binding proteins
08/24/2000CA2362538A1 Secreted proteins and polynucleotides encoding them
08/24/2000CA2362334A1 Dibenzo-azepine derivatives as .alpha.v integrin receptor antagonists
08/24/2000CA2362306A1 Chemical compounds
08/24/2000CA2362303A1 Growth hormone secretagogues
08/24/2000CA2362290A1 Novel amide derivatives as growth hormone secretagogues
08/24/2000CA2360353A1 2-amino-6-anilino-purines and their use as medicaments
08/24/2000CA2262056A1 Composition, methods and reagents for the synthesis of a soluble form of human pex
08/23/2000EP1029851A1 Piperazine compounds and medicinal use thereof
08/23/2000EP1029545A2 Composition for oral administration of nutritional supplement or medicaments in tablet form
08/23/2000EP1029035A1 Method for inducing osteoblast differentiation of human extramedullary adipose tissue cells
08/23/2000EP1028977A2 Bifidus stimulating peptides
08/23/2000EP1028975A1 Artemin, a novel neurotrophic factor
08/23/2000EP1028974A1 Secreted proteins and polynucleotides encoding them
08/23/2000EP1028957A1 Piperidine derivatives and their use as tachykinin antagonists
08/23/2000EP1028955A1 Pyrimidinone compounds and pharmaceutical compositions containing them
08/23/2000EP1028954A1 Substituted imidazoles useful in the treatment of inflammatory diseases
08/23/2000EP1028951A1 Diaryl-5-alkyl-5-methyl-2(5h)-furanones as selective cyclooxygenase-2 inhibitors
08/23/2000EP1028945A1 Substituted pyridine compounds as anti-inflammatory agents
08/23/2000EP1028942A2 Dipeptide nitriles
08/23/2000EP1028710A1 Topical compositions for nsai drug delivery
08/23/2000EP0821668B1 Derivatives of succinamide and their use as metalloproteinase inhibitor
08/23/2000CN1264427A Osteoprotegernin binding proteins and receptors
08/23/2000CN1264382A Novel compounds
08/23/2000CN1264377A Substituted pyrazoles as P38 kinase inhabitors
08/23/2000CN1264376A 3(5)-Heteroaryl substituted pyrazoles as P38 kinase inhibitors
08/23/2000CN1263771A Black plaster and preparing process thereof
08/23/2000CN1263767A Medical wine for treating rheumatism, fracture and injury and preparing process thereof
08/23/2000CN1055697C Phospholipi derivatives containing higher elements of the Vth main group
08/23/2000CN1055626C Orally traditional Chinese medicine for orthopedics disease
08/22/2000US6107473 Kringle-related clone HTHBZ47
08/22/2000US6107338 Aromatic C16 -C20 -substituted tetrahydro prostaglandins useful as FP agonists
08/22/2000US6107335 Esculentin A and esculentin B, a process for their preparation, and their use in the manufacture of medicaments
08/22/2000US6107334 Dietary control of arachidonic acid metabolism
08/22/2000US6107311 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
08/22/2000US6107306 Heterocyclic compounds
08/22/2000US6107305 Antiproferative agent, antiinflammatory agents
08/22/2000US6107291 Antiinflammatory agent
08/22/2000CA2176973C Phenyl heterocycles as cyclooxygenase-2 inhibitors
08/17/2000WO2000047736A1 Polypeptide variants with raised heparin-binding capacity
08/17/2000WO2000047625A2 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith
08/17/2000WO2000047620A1 Cytokine-binding domain
08/17/2000WO2000047619A1 Therapeutics and diagnostics based on an il-1b mutation
08/17/2000WO2000047603A2 16-hydroxyestratrienes as selective estrogens
08/17/2000WO2000047602A1 33 human secreted proteins
08/17/2000WO2000047583A1 Cyclic substituted fused pyrrolocarbazoles and isoindolones
08/17/2000WO2000047580A2 Phenyl urea and phenyl thiourea derivatives
08/17/2000WO2000047578A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors
08/17/2000WO2000047565A1 Pyrimidine-2,4,6-triones as inhibitors of matrix metalloproteinases
08/17/2000WO2000047564A1 Novel guanidine derivatives as inhibitors of cell adhesion
08/17/2000WO2000047562A1 Spirocyclic ketones and their use as tachykinin antagonists
08/17/2000WO2000047552A1 Tyrosine alkoxyguanidines as integrin inhibitors
08/17/2000WO2000047231A2 Novel antisense inhibition of rad51
08/17/2000WO2000047212A1 Quinazoline derivatives as angiogenesis inhibitors
08/17/2000WO2000047210A1 Use of 4-amino pyridine for treatment of peripheral neuropathies
08/17/2000WO2000047194A2 METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR
08/17/2000WO2000047130A1 Injectable collagen-based system for delivery of cells or therapeutic agents
08/17/2000WO2000047049A1 Method for reducing hip joint laxity
08/17/2000WO2000033837A3 Myt1 kinase inhibitors
08/17/2000WO2000027819A3 Antrhranilic acid amides and the use thereof as medicaments
08/17/2000WO2000014230A9 Novel molecules of the herpes virus-entry-mediator-related protein family and uses thereof
08/17/2000DE19906096A1 Protein mit einem Heparin-bindenden Epitop Protein having a heparin-binding epitope
08/17/2000DE19906016A1 Zubereitung für oral zu verabreichende Nahrungsergänzungs- und/oder Arzneimittel in Form von Tabletten Preparation for oral nutritional supplements and / or drug in pill form
08/17/2000CA2362592A1 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith
08/17/2000CA2362390A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors
08/17/2000CA2362372A1 Tyrosine alkoxyguanidines as integrin inhibitors
08/17/2000CA2362272A1 Spirocyclic ketones and their use as tachykinin antagonists
08/17/2000CA2362109A1 Novel antisense inhibition of rad51
08/17/2000CA2361569A1 Injectable collagen-based system for delivery of cells or therapeutic agents
08/17/2000CA2361293A1 33 human secreted proteins
08/17/2000CA2360233A1 Methods of treating c1s-mediated diseases and conditions, and compounds and compositions therefor
08/17/2000CA2359660A1 16-hydroxyestratrienes as selective estrogens
08/16/2000EP1028137A2 Polymeric matrices and their uses in pharmaceutical compositions
08/16/2000EP1028114A1 Novel guanidine derivatives as inhibitors of cell adhesion
1 ... 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 ... 820